GlassScriptFujirebio Diagnostics, Incorporated
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$306Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
77clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Robert Knapp | Lantana, FL | Obstetrics & Gynecology | $131,250.00 |
| Richard Moore | Rochester, NY | Gynecologic Oncology | $120,174.66 |
| Jorge Nieva | Los Angeles, CA | Hematology & Oncology | $14,607.73 |
| Christopher Defilippi | Baltimore, MD | Cardiovascular Disease | $9,060.00 |
| William Hu | New Brunswick, NJ | Behavioral Neurology & Neuropsychiatry | $3,500.00 |
| Kenneth Chen | Providence, RI | Internal Medicine | $3,496.86 |
| Kenneth Chen | Richmond, CA | Nephrology (Internal Medicine) | $2,867.57 |
| Bryan Burt | Los Angeles, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $2,400.00 |
| Hartmut Malluche | Lexington, KY | Nephrology (Internal Medicine) | $2,300.00 |
| Edgardo Santos | Fort Lauderdale, FL | Hematology & Oncology | $2,258.34 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.